ecancermedicalscience

Policy

Cancer disease progression and death during the COVID-19 pandemic: a multidisciplinary analysis for the Peruvian setting

8 Sep 2020
Juan Astigueta-Pérez, Milagros Abad-Licham, Carlos Chávez-Chirinos, Luis Beraun-Milla, Alberto Lachos-Dávila, Elizabeth Diaz-Pérez, Karem Portugal-Valdivia, Paul Pilco Castañeda, Isaías Pérez Alférez, Edward Mezones-Holguín

Since the COVID-19 pandemic began in China in late 2019, infection from the SARS-CoV-2 virus has spread virtually worldwide. This infection has adversely affected several countries; governments have outlined a series of political measures aimed to preserve the health and safety of their populations. In Peru, most actions have prioritised COVID-19 attention, with a subsequent gap in the healthcare facilities needed for other diseases. Cancer, one principal cause of death in the country, is usually diagnosed late. Moreover, in the pandemic context, the prevention and control of cancer have been negatively affected. Therefore, we carried out a multidisciplinary analysis using the Ishikawa diagram to identify the probable factors that contribute to cancer progression and deaths in Peru.

Related Articles

Prajwal Dhakal, Christopher S Wichman, Shailesh Simkhada, Bunny J Pozehl, Radowan Elnair, Amulya Yellala, Kalika Mahato, Vijaya Raj Bhatt
Prasoon Mishra, Rahat Hadi, Ajeet Kumar Gandhi, Madhup Rastogi, Rohini Khurana, Ashish Singhal, Surendra Prasad Mishra, Anoop Srivastava, Avinav Bharati, Ashish Chandra Agarwal, Avinash Poojari, Vachaspati Kumar Mishra, Raunaq Puri, Akanksha Manral, Vikas Gupta, Bhoopendra Pratap Vishwaranjan, Saumyta Mishra
Navjot Kaur, Pritam Halder, Yuvaraj Krishnamoorthy, Gursimer Jeet, Garima Bhatt, Sathish Rajaa, Priyanka Sudhir, Rohit Sharma, Sarthak Tandon, Manish Gupta
María Valeria Jiménez-Báez, Sofía Concepción Thomas-Gómez, Gabriel González-Guerrero, David Rojano-Mejía, Eduardo Patricio Achurra-Godinez